IRIS

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma / Robert, C; Long, Gv; Brady, B; Dutriaux, C; Di Giacomo, Am; Mortier, L; Rutkowski, P; Hassel, Jc; Mcneil, Cm; Kalinka, Ea; Lebbe, C; Charles, J; Hernberg, Mm; Savage, Kj; Chiarion-Sileni, V; Mihalcioiu, C; Mauch, C; Arance, A; Cognetti, F; Ny, L; Schmidt, H; Schadendorf, D; Gogas, H; Zoco, J; Re, S; Ascierto, P; Atkinson, V. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 38:33(2020). [10.1200/JCO.20.00995]

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

Ascierto P;
2020
2020
Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma / Robert, C; Long, Gv; Brady, B; Dutriaux, C; Di Giacomo, Am; Mortier, L; Rutkowski, P; Hassel, Jc; Mcneil, Cm; Kalinka, Ea; Lebbe, C; Charles, J; Hernberg, Mm; Savage, Kj; Chiarion-Sileni, V; Mihalcioiu, C; Mauch, C; Arance, A; Cognetti, F; Ny, L; Schmidt, H; Schadendorf, D; Gogas, H; Zoco, J; Re, S; Ascierto, P; Atkinson, V. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 38:33(2020). [10.1200/JCO.20.00995]
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1014483
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 198
  • ???jsp.display-item.citation.isi??? 189
social impact